Cancer Neutron Capture Therapy

Nonfiction, Health & Well Being, Medical, Specialties, Dermatology, Oncology
Cover of the book Cancer Neutron Capture Therapy by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781475795677
Publisher: Springer US Publication: June 29, 2013
Imprint: Springer Language: English
Author:
ISBN: 9781475795677
Publisher: Springer US
Publication: June 29, 2013
Imprint: Springer
Language: English

There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

There are many human cancers which actively synthesize specific characteristic proteins such as melanomas, thyroid cancer and squamous cell carcinoma. Many cancer researchers have of course tried to utilize this specific activity as a key for the selective treatment of cancers. In the past for example, the molecular hybrid compound of DOPA, a substrate of melanin, and nitrogen mustard N-oxide hydrochloride, a ctyotoxic anti-tumor drug, was synthesized as Melphalan and used to treat malignant melanoma. A major problem arose though in that it was soon found to be highly suppressive toward bone marrow and quite toxic while not being remarkably effective. Thus, malignant melanoma could not be cured by it. Such failure led us to develop a novel bimodal therapeutic system which includes the use of non-toxic potentially cytocidal chemicals which selectively accumulate within the cancer cells and which are converted by a controllable modality into an actively cytocidal element in situ. We can now non-surgically cure malignant melanoma and glioblastoma with our selective cancer treatment, neutron capture therapy (NCT); as can be found in this volume. Included are 124 papers on the latest breaking developments discussed at the Sixth International Symposium on NCT for Cancer held in Kobe during the late autumn of 1994.

More books from Springer US

Cover of the book Parent-Child Interaction by
Cover of the book Endocrine and Metabolic Effects of Lithium by
Cover of the book Environmental Effects on Volcanic Eruptions by
Cover of the book Attention and Cognitive Development by
Cover of the book Handbook of Nonverbal Assessment by
Cover of the book System-on-Chip Architectures and Implementations for Private-Key Data Encryption by
Cover of the book Molecular Gerontology by
Cover of the book Recent Advances in Plant Biotechnology by
Cover of the book Magnetic Oxides by
Cover of the book Adolescent Substance Abuse by
Cover of the book Coping with HIV Infection by
Cover of the book ECG Holter by
Cover of the book Computer Architecture: A Minimalist Perspective by
Cover of the book Cushing's Disease by
Cover of the book Mechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy